Search results
Alkermes' (ALKS) Q1 Earnings & Revenues Fall Shy of Estimates
Zacks via Yahoo Finance· 16 hours agoRecent Updates Last month, Alkermes announced positive top-line data from a phase Ib study...
Trump Is Now Raging at His Own Lawyer—and Wrecking a Big MAGA Fantasy
The New Republic via Yahoo News· 2 days agoTrump also promoted a video of Fox’s Jeanine Pirro insisting that it showcases his ability to...
Earnings call: Harmony Biosciences maintains strong growth, eyes future launches By Investing.com
Investing.com· 2 days agoHarmony Biosciences (ticker: HRMY) has reported a solid start to the year with a 30% increase in...
Earnings call: Alkermes reports solid Q1 2024 results, optimistic about pipeline By Investing.com
Investing.com· 1 day agoThe neuroscience company reported net sales for VIVITROL at $97.7 million, ARISTADA at $78.9...
Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates
Zacks via Yahoo Finance· 17 hours agoXywav, a low-sodium formulation of Xyrem, recorded sales of $315.3 million in the quarter, up 14%...
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoHarmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript April 30, 2024...
Alkermes plc Reports First Quarter 2024 Financial Results
FOX21 Colorado Springs· 2 days agoAlkermes plc (Nasdaq: ALKS) today reported financial results for the first quarter of 2024. With these new data now in hand, we plan to initiate a phase 2 study in narcolepsy type 2 in the second half of 2024.
Needham raises Harmony Biosciences stock target on growth strategy By Investing.com
Investing.com· 2 days ago(NASDAQ: NASDAQ:HRMY) to $52, up from the previous $50, while maintaining a Buy rating on the stock....
Earnings call: Jazz Pharmaceuticals sustains growth with key drivers By Investing.com
Investing.com· 21 hours agoJazz Pharmaceuticals PLC (NASDAQ:JAZZ) has reported robust first-quarter 2024 results, showcasing...
Harmony Biosciences Exceeds Analyst Revenue Forecasts While Aligning with EPS Projections in Q1 2024
GuruFocus.com via Yahoo Finance· 3 days agoTheir flagship product, WAKIX (pitolisant), has been a critical driver of revenue growth,...